Sechenov School
Home › Pathophysiology › Neurodystrophic Process

Neurodystrophic Process

For medical students2 min readUpdated 2026-10-10

Neurodystrophic process is a pathological condition based on the impairment of the trophic function of the nervous system. Such a disturbance leads to profound metabolic alterations in innervated structures, causing hypotrophy, ulceration, and organ dysfunction.

Primary CauseDenervation syndrome (impairment of axonal transport)
LocalizationTarget cells of organs, tissues, and within the nervous system itself
Severe OutcomeDevelopment of neurotrophic ulcers and potential malignant transformation
Contributing FactorNeuroses (higher nervous activity disorders), affecting 20–30% of the population

Mechanisms of Nervous System Influence on Cell Metabolism

To understand the essence of this pathology, it is necessary to examine how the nervous system controls metabolism in healthy tissues. There are five fundamental pathways of action on target cells:

  1. Impulse activity patterns. A specific temporal pattern of nerve discharges serves as a unique code transmitting information required to regulate metabolic cascades.
  2. Alteration of axonal transport. Trophogens—special proteins and peptides—are continuously delivered to peripheral tissues via neuronal processes (axons).
  3. Modulation of membrane permeability. Nerve terminals can alter the ionic homeostasis of the target cell, which directly affects the activity of intracellular enzymes.
  4. Trophic secretion of neurotransmitters. So-called 'small' (background) quantities of neurotransmitter quanta are constantly released into the synaptic cleft. This process occurs spontaneously, independently of excitatory signal transmission, and is critical for maintaining the viability of the postsynaptic structure.
  5. Electrical potential shift. Influencing the resting potential of both pre- and postsynaptic membranes alters substance transport and overall cell excitability.

Implementation of Trophic Function

Neurotrophic control is mediated through three main mechanisms, the disruption of which triggers dystrophic changes:

Denervation Syndrome and Deafferentation

The typical etiological basis of the neurodystrophic process is denervation syndrome. It is rooted in the cessation of axonal transport, which has been extensively studied using skeletal muscle denervation models. As a result, typical metabolic disorders develop in postsynaptic structures.

However, pathology can occur not only from efferent (motor) pathway lesions but also from damage to afferent structures (e.g., transection or mechanical trauma of a sensory nerve). This condition is termed tissue deafferentation. The loss of sensory impulse traffic leads to trophic shifts comparable in severity to the consequences of classical motor denervation.

Thy neurodystrophic component is present in virtually all forms of human disease, ranging from mechanical trauma to functional disorders.

Clinical and Structural Manifestations

Trophic impairment leads to severe systemic consequences. The main manifestations of the neurodystrophic process include:

Against the backdrop of somatic disorders, functional disorders of the nervous system itself, such as neuroses (higher nervous activity disorders), must not be overlooked. They affect 20–30% of the population, carry immense socio-economic significance, and exacerbate patients' overall condition.

Mnemonic

To remember the 3 stages of growth factor action: Synthesis (in the neuron) → Transport (along the axon) → Secretion (into the synapse). Abbreviated as: STS.

Frequently asked questions

What specific biochemical and metabolic disorders develop in the cell during denervation syndrome?

During denervation syndrome, dysenzymoplasia and metabolic 'embryonalization' develop in the cell. Metabolism acquires features of early ontogenetic stages: oxidative processes decrease, anaerobic glycolysis dominates, and the pentose phosphate pathway is activated. Additionally, lysosomal membrane labilization with enzyme release and disruption of plasmalemma selective permeability occur.

What specific types of neurotrophic factors (trophogens) are transported via axons to peripheral tissues?

Various groups of trophogens are transported via axons to peripheral tissues:

  • Primary trophogens — nucleotides, certain amino acids, prostaglandins, catecholamines, serotonin, acetylcholine, complex lipids, gangliosides, substance P, CGRP.
  • Oligopeptides — liberins, statins, enkephalins, endorphins, bradykinin, neurotensin, cholecystokinin, ACTH fragments, oxytocin.
  • Growth factors — nerve growth factor (NGF), epidermal growth factor (EGF), insulin-like growth factor (IGF), tumor necrosis factor (TNF).
What is the essence of denervation syndrome?

It is a complex of typical disorders in the postsynaptic cell resulting from impaired axonal transport of trophogens and neurotransmitters following nerve damage.

Can tissue dystrophy occur while motor innervation remains intact if sensory innervation is lost?

Yes, damage to afferent (sensory) pathways causes deafferentation, leading to trophic disturbances comparable to the consequences of motor nerve destruction.

How does resting neurotransmitter release affect trophics?

Spontaneous release of small amounts of neurotransmitter (without excitatory signal transmission) is necessary to maintain basal viability and structural integrity of the postsynaptic cell.

Go deeper

More topics in Pathophysiology

Protein, Lipid, and Ion Metabolism Atypism in TumorsMiddle Stage of Substance Use DisorderLeukocytosisHeart Failure: Pathophysiology and Clinical ManifestationsRespiratory Distress Syndrome in NewbornsGastric Motility Disorders: Pathophysiology and MechanismsHeartburn, Nausea, and VomitingComaNeurosis: Pathophysiology, Types and Clinical FormsSystemic Inflammatory Response Syndrome (SIRS)Etiological Factors in PathologyMethods for Diagnosing Hereditary DiseasesPathophysiology →